CMXHFCSL Ltd.

About CSL Ltd. (CMXHF)

CSL Ltd. (CMXHF) is a Biotechnology company headquartered in Melbourne, VA, Australia whose shares trade over-the-counter on the OTCQX tier.

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.

Products and services

Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

CMXHF key facts

Ticker symbol

CMXHF

Market tier

OTCQX

Sector

Healthcare

Industry

Biotechnology

Headquarters

Melbourne, VA, Australia

Country of incorporation

AU

Year of incorporation

1991

Employees

32,000

Estimated market cap

$67.52B (as of Apr 11, 2025)

Shares outstanding

484,212,123

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Latest filing

Semi-Annual Report (Dec 31, 2024)

CSL Ltd. leadership

• Paul McKenzie — CEO
• Joy Linton — CFO
• Accounts Payable - CSL — Accountant
• Chris Cooper — Head of IR
• Fiona Mead — Company Secretary

Explore more: Biotechnology stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with C